Smoking Cessation

Medications aimed at helping people stop smoking are designed to reduce withdrawal symptoms, control cravings and support behavior change when someone decides to quit tobacco. They work on the physical aspects of nicotine dependence or on brain chemistry related to craving and reward, and are most effective when combined with counseling or other support. These products are used by a wide range of adults who want to stop smoking or to reduce their dependence on combustible tobacco products.

Typical situations in which these medicines are used include making an initial quit attempt, preventing relapse after a recent quit, or reducing cigarette consumption as part of a planned stop-smoking strategy. Many people use pharmacological aids alongside stop-smoking programs, telephone or online support, and behavior-change techniques. Some individuals start medication before their chosen quit date, while others begin on the day they stop smoking; patterns of use vary depending on the product and personal circumstances.

Different classes of medicines are available. Nicotine replacement therapies (NRT) deliver controlled amounts of nicotine without the thousands of other chemicals found in cigarette smoke and come in several forms such as patches, gum, lozenges, inhalers and nasal sprays. Prescription non-nicotine options work on brain receptors involved in addiction; common examples include varenicline (widely known by some brand names) and bupropion in its immediate- and sustained-release formulations, which have both been used as aids for smoking cessation. Products in this category may be over-the-counter or prescription-only depending on the country and formulation.

How these medications are typically used varies by type. NRT products can be applied or taken regularly to maintain a steady nicotine level or used intermittently to manage breakthrough cravings. Prescription agents are usually taken on a regular schedule and are often started before or at the time of quitting, with a planned course duration determined by clinical guidance and individual response. Health professionals recommend combining medication with behavioral support to improve the chances of success; exact regimens and durations should be based on product information and a clinician’s assessment.

General safety considerations include potential side effects, drug interactions and special precautions for people with certain medical conditions. Common side effects depend on the product and may include local effects from patches or gum, nausea, sleep disturbances or mood changes from oral medications. People who are pregnant, breastfeeding, have a history of seizures, cardiovascular disease, or certain psychiatric conditions should seek professional assessment before starting a medicine for quitting smoking. Product leaflets and healthcare providers are important sources of information about contraindications and monitoring.

When choosing a smoking cessation medicine, users often weigh factors such as effectiveness, side effect profiles, ease of use, route of administration and whether a prescription is required. Some look for short-acting options to manage sudden cravings, while others prefer steady-delivery choices for continuous symptom control. Practical considerations include the need for behavioral support, previous quit attempts and personal medical history. Decisions about which approach to try are typically made with input from a healthcare professional or a stop-smoking adviser.